Related Experiment Video

Updated: Jun 7, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

[Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction

C Templin1, T F Lüscher, U Landmesser

  • 1Klinik für Kardiologie, UniversitätsSpital Zürich, Rämistr. 100, 8091, Zürich, Schweiz. Christian.Templin@usz.ch

Herz
|October 23, 2010
PubMed

Insights

Stem cell therapies offer promising regenerative potential for acute myocardial infarction patients who develop adverse cardiac remodeling despite optimal treatment. Research explores various cell types and delivery methods to improve heart function and prognosis.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Cell Therapy

Context:

  • Acute myocardial infarction (AMI) often leads to adverse left ventricular (LV) remodeling and dysfunction, despite percutaneous coronary intervention (PCI) and optimized pharmacological treatment.
  • A significant portion of patients experience poor prognosis due to persistent cardiac remodeling and LV dysfunction post-AMI.
  • Cell-based approaches represent a promising frontier for treating ischemic heart disease and improving cardiac repair.

Purpose:

  • To review recent advancements in stem and progenitor cell-based therapies for acute myocardial infarction and chronic ischemic cardiomyopathy.
  • To assess the regenerative capacity of various stem and progenitor cell populations in cardiac repair.
  • To discuss the advantages and disadvantages of different cell delivery methods and strategies for enhancing cell function in cardiovascular therapies.

Summary:

  • PCI and optimal medical therapy reduce but do not eliminate adverse cardiac remodeling post-MI.
  • Stem and progenitor cell therapies are under investigation for their potential to repair and regenerate heart tissue after myocardial infarction.
  • This review covers cell types, application methods, and strategies to improve cell-based cardiovascular treatments.

Impact:

  • Highlights the potential of stem cell therapy to improve outcomes for patients with ischemic heart disease.
  • Provides a comprehensive overview of current research in regenerative cardiology.
  • Informs future clinical strategies for cell-based cardiovascular regeneration and treatment.

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Intramyocardial Cell Delivery: Observations in Murine Hearts08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...